Company intelligence / Profile preview
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shenzhen, Guangdong, Chinasalubris.com ↗
- Ownership
- Private
- Employees
- ~3121
- Development stage
- Commercial
01
Overview
The company has multiple products in various clinical stages, from pre-clinical to commercial. Their lead product JK07 for heart failure has enrolled its first patient in Phase 2 clinical trials. They also have promising candidates in oncology and other therapeutic areas.
- Therapeutic areas
- PsychiatryCardiovascularNephrologyEndocrinologyOncology
- Modalities
- Small moleculesBiological medicinesMedical devicesAntibody fusion proteinsAntibody-drug conjugates (ADCs)Cell and gene therapy
- Industry
- Biotech
02
Drug pipeline
33 assets32 more assets in the full pipeline.
03
Partnerships
YolTech TherapeuticsCarlyle
Beyond the preview
Go deeper on Shenzhen Salubris Pharmaceuticals Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Salubris Pharmaceuticals Co., Ltd..